Trial intelligence / Profile preview

Phase II pilot study of conversion from Prograf to prolonged-release tacrolimus in stable lung transplant recipients

2009-015863-15Phase 2Completed

Sponsor: Dr. Antonio RomÃ¡n Broto
Start: Feb 2010
Modality: RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
Countries: 1

Overview

Phase 2, open-label, single-arm trial of tacrolimus in lung transplant complications, sponsored by Dr. Antonio RomÃ¡n Broto. Primary endpoints: Tacrolimus pharmacokinetic parameters, Biopsy-proven acute rejection incidence and 1 more. Started Feb 2010; status: completed.

Drugs

tacrolimus

Conditions

lung transplant complications

Beyond the preview

Go deeper on 2009-015863-15.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-015863-15.